Claims
- 1. A process for producing a 5-alkyl-oxazolidin-2,4-dione represented by formula (2), comprising reacting a 2-hydroxycarboxylic acid amide represented by formula (1) with a carbonic acid ester in the presence of a metal alcoholate:
- 2. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in claim 1, wherein the used 2-hydroxycarboxylic acid amide has a water content of 5 mass % or less.
- 3. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in claim 1 or 2, wherein a crystal of the 2-hydroxycarboxylic acid amide is used.
- 4. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in any one of claims 1 to 3, wherein the used 2-hydroxycarboxylic acid amide has an acidic component content of 5 mass % or less in terms of sulfuric acid.
- 5. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in any one of claims 1 to 4, wherein the metal alcoholate is a sodium alcoholate.
- 6. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in claim 5, wherein the sodium alcoholate is sodium methylate and/or sodium ethylate.
- 7. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in any one of claims 1 to 6, wherein the carbonic acid ester is at least one ester selected from the group consisting of dimethyl carbonate, diethyl carbonate, methyl chlorocarbonate and ethyl chlorocarbonate.
- 8. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in any one of claims 1 to 7, wherein the equivalent ratio of the 2-hydroxycarboxylic acid amide, the carbonic acid ester and the metal alcoholate is 1:1.0 to 1.5:1.0 to 1.5.
- 9. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in any one of claims 1 to 8, wherein the water content in the solution of starting materials other than the metal alcoholate is 3 mass % or less.
- 10. A process for producing a 5-alkyl-oxazolidin-2,4-dione, comprising the step of isolating the 5-alkyl-oxazolidin-2,4-dione represented by formula (2) from the 5-alkyl-oxazolidin-2,4-dione metal salt represented by formula (3) obtained in the reaction solution resulting from the process claimed in any one of claims 1 to 9, the reaction solution is neutralized with a mineral acid to adjust the pH:
- 11. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in claim 10, wherein the neutralization with a mineral acid is performed in parts of twice or more to adjust the final hydrogen ion concentration of the solution to a pH of 5 or less.
- 12. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in claim 11, wherein the reaction solution is adjusted to a pH of 6 to 10 by the neutralization with a mineral acid and after the adjustment of concentration, the final hydrogen ion concentration is adjusted to a pH of 5 or less by the neutralization with a mineral acid.
- 13. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in claim 12, wherein the alcohol concentration is adjusted to 7 mass % or less by distilling off the alcohol.
- 14. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in claim 12 or 13, wherein the concentration of 5-alkyl-oxazolidin-2,4-dione in the solution is adjusted to from 10 to 40 mass %.
- 15. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in claim 10, wherein the reaction solution is adjusted to a pH of 9 or less by the neutralization with a mineral acid and after the adjustment of concentration, cooled.
- 16. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in claim 15, wherein the alcohol concentration is adjusted to 7 mass % or less by distilling off the alcohol.
- 17. The production process for 5-alkyl-oxazolidin-2,4-dione as claimed in claim 15 or 16, wherein the concentration of 5-alkyl-oxazolidin-2,4-dione in the solution is adjusted to from 10 to 40 mass %.
- 18. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in any one of claims 10 to 17, wherein after adjusting the pH by the neutralization with a mineral acid, the concentration of inorganic salts contained in the solution is adjusted to from 10 to 35 mass % in the solution.
- 19. A process for producing a 5-alkyl-oxazolidin-2,4-dione, comprising dissolving a low-purity 5-alkyl-oxazolidin-2,4-dione in an aqueous alkali metal hydroxide solution and recrystallizing it by neutralization to obtain a high-purity 5-alkyl-oxazolidin-2,4-dione.
- 20. The process for producing a 5-alkyl-oxazolidin-2,4dione as claimed in claim 19, wherein the purity of the low-purity 5-alkyl-oxazolidin-2,4-dione is from 90.0 to less than 99.0 mass % and the purity of the high-purity 5-alkyl-oxazolidin-2,4-dione is 99.0 mass % or more.
- 21. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in claim 19 or 20, wherein the alkyl group at the 5-position of 5-alkyl-oxazolidin-2,4-dione is an alkyl group having from 1 to 4 carbon atoms.
- 22. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in claim 21, wherein the alkyl group at the 5-position is an ethyl group, a propyl group or a butyl group.
- 23. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in any one of claims 1 to 18, which further comprises a step of dissolving a 5-alkyl-oxazolidin-2,4-dione in an aqueous alkali metal hydroxide solution and recrystallizing it by neutralization to obtain a high-purity 5-alkyl-oxazolidin-2,4-dione.
- 24. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in any one of claims 1 to 18, wherein the organic solvent which can be recovered from the reaction solution is reused.
- 25. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in any one of claims 1 to 18, 23 and 24, wherein the 2-hydroxycarboxylic acid amide is 2-hydroxyhexanoic acid amide and the 5-alkyl-oxazolidin-2,4-dione is 5-butyl-oxazolidin-2,4-dione.
- 26. The process for producing a 5-alkyl-oxazolidin-2,4-dione as claimed in any one of claims 19 to 22, wherein the 5-alkyl-oxazolidin-2,4-dione is 5-butyl-oxazolidin-2,4-dione.
- 27. A 5-alkyl-oxazolidin-2,4-dione having a purity of 99.0% or more.
- 28. The 5-alkyl-oxazolidin-2,4-dione as claimed in claim 27, wherein the content of inorganic salts is 0.2% or less.
- 29. A 5-butyl-oxazolidin-2,4-dione having a purity of 99.0% or more.
- 30. The 5-butyl-oxazolidin-2,4-dione as claimed in claim 29, wherein the content of inorganic salts is 0.2% or less.
Priority Claims (2)
Number |
Date |
Country |
Kind |
2001-170044 |
Jun 2001 |
JP |
|
2001-175713 |
Jun 2001 |
JP |
|
CROSS REFERENCES OF RELATED APPLICATIONS
[0001] This application is an application filed under 35 U.S.C. §111(a) claiming benefit pursuant to 35 U.S.C. §119(e) (1) of the filing date of provisional Application No. 60/297,787 filed on Jun. 14, 2001, pursuant to 35 U.S.C. §111 (b).
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
PCT/JP02/05480 |
6/4/2002 |
WO |
|